GSK India "Women's Board" Sets Out To Close Gender Gap
GlaxoSmithKline, which will be led by a woman CEO next year, is taking definitive steps to improve the gender balance at its Indian operations. A new "Women's Leadership Board" at GSK India is expected to bolster gender diversity across levels and develop a pipeline of female leaders for key senior positions.
You may also be interested in...
One woman CEO is an improvement, but at this rate gender equality won't arrive before immuno-oncology goes generic.
GSK’s new CEO will be Emma Walmsley, currently head of its Consumer Healthcare division. While some investors had wished for a company outsider with a ‘fresh pair of eyes’, GSK’s board decided to go for the best of both worlds: an insider with plenty of non-pharma experience.
Tildrakizumab debuts in Japan, marking a key milestone for Sun Pharma, though heavyweight competitors including same class rival Skyrizi are already available on the market there.